Concepedia

Paul Mésange

PM

5

Publications

363

Citations

5

H-Index

2014

Active since

Affiliations

Hôpital Saint-Antoine(Current)

Sorbonne Université

Methodology and Quality of Life Unit in Oncology

Institut Paoli-Calmettes

Institut Hospitalier Franco Britannique

Paul Mésange is an author at Hôpital Saint-Antoine specializing in radiation oncology, cancer therapeutics, and colorectal cancer.

Top concepts

Publications per year

2014–2018

5

Publications

5

Dominant Role for Regulatory T Cells in Protecting Females Against Pulmonary Hypertension

Rasa Tamošiūnienė, Olga Manouvakhova, Paul Mésange et al. · Circulation Research · 2018 · 137 citations · Full text

Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial

Christophe Tournigand, Benoist Chibaudel, Benoît Samson et al. · The Lancet Oncology · 2015 · 120 citations

, , +8

Intrinsic bevacizumab resistance is associated with prolonged activation of autocrine VEGF signaling and hypoxia tolerance in colorectal cancer cells and can be overcome by nintedanib, a small molecule angiokinase inhibitor

Paul Mésange, Virginie Poindessous, Michèle Sabbah et al. · Oncotarget · 2014 · 71 citations · Full text

Combinations of Bevacizumab and Erlotinib Show Activity in Colorectal Cancer Independent of <i>RAS</i> Status

Paul Mésange, Anaïs Bouygues, Nathalie Ferrand et al. · Clinical Cancer Research · 2018 · 25 citations · Full text

Bevacizumab-Erlotinib As Maintenance Therapy in Metastatic Colorectal Cancer. Final Results of the Gercor Dream Study

Benoist Chibaudel, Christophe Tournigand, Benoît Samson et al. · Annals of Oncology · 2014 · 10 citations

, , +9

Rows per page

1–5 of 5